Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial (Q34266113)

1 August 2017

title

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial (English)

1 reference

1 August 2017

0 references

0 references

16

Janet S Carpenter

1 reference

1 August 2017

Garnet L Anderson

9

0 references

Kathryn M. Rexrode

object named as

Kathryn M Rexrode

series ordinal

13

0 references

Hadine Joffe

series ordinal

1

object named as

Hadine Joffe

1 reference

1 August 2017

14

Bette Caan

1 reference

1 August 2017

6

JoAnn E Manson

1 reference

1 August 2017

5

Kristine E Ensrud

1 reference

1 August 2017

15

Barbara Sternfeld

1 reference

1 August 2017

3

Andrea Z LaCroix

1 reference

1 August 2017

10

Joseph C Larson

1 reference

1 August 2017

17

Lee Cohen

1 reference

1 August 2017

2

Katherine A Guthrie

1 reference

1 August 2017

11

Julie Hunt

1 reference

1 August 2017

12

Jan Shifren

1 reference

1 August 2017

4

Susan D Reed

1 reference

1 August 2017

7

Katherine M Newton

1 reference

1 August 2017

Ellen W Freeman

8

1 reference

1 August 2017

publication date

1 July 2014

1 reference

1 August 2017

published in

JAMA Internal Medicine

1 reference

1 August 2017

volume

174

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1058-1066

1 reference

Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

The 2012 hormone therapy position statement of: The North American Menopause Society

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Non-hormonal interventions for hot flushes in women with a history of breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Hot flushes: are there effective alternatives to estrogen?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

A brief measure for assessing generalized anxiety disorder: the GAD-7.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Vasomotor symptom relief versus unwanted effects: role of estrogen dosage

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Initial 17beta-estradiol dose for treating vasomotor symptoms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

A global measure of perceived stress

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Health care-seeking for menopausal problems

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Validation of the Insomnia Severity Index as an outcome measure for insomnia research

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179877

Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation

28 October 2018

1 reference

12 December 2020

The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer

1 reference

12 December 2020

The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function

1 reference

12 December 2020

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

1 reference

12 December 2020

10.1001/JAMAINTERNMED.2014.1891

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference